F Stephen Hodi, Steven J O'Day, David F McDermott, Robert W Weber, Jeffrey A Sosman, John B Haanen, Rene Gonzalez, Caroline Robert, Dirk Schadendorf, Jessica C Hassel, Wallace Akerley, Alfons J M van den Eertwegh, Jose Lutzky, Paul Lorigan, Julia M Vaubel, Gerald P Linette, David Hogg, Christian H Ottensmeier, Celeste Lebbé, Christian Peschel, Ian Quirt, Joseph I Clark, Jedd D Wolchok, Jeffrey S Weber, Jason Tian, Michael J Yellin, Geoffrey M Nichol, Axel Hoos, Walter J Urba. N Engl J Med 2010
Times Cited: 9840
Times Cited: 9840
James Larkin, Vanna Chiarion-Sileni, Rene Gonzalez, Jean-Jacques Grob, Piotr Rutkowski, Christopher D Lao, C Lance Cowey, Dirk Schadendorf, John Wagstaff, Reinhard Dummer, Pier F Ferrucci, Michael Smylie, David Hogg, Andrew Hill, Ivan Márquez-Rodas, John Haanen, Massimo Guidoboni, Michele Maio, Patrick Schöffski, Matteo S Carlino, Céleste Lebbé, Grant McArthur, Paolo A Ascierto, Gregory A Daniels, Georgina V Long, Lars Bastholt, Jasmine I Rizzo, Agnes Balogh, Andriy Moshyk, F Stephen Hodi, Jedd D Wolchok. N Engl J Med 2019
Times Cited: 1225
Times Cited: 1225
List of shared articles
Times cited
Efficacy and safety of anti-PD-1 inhibitor combined with nab-paclitaxel in Chinese patients with refractory melanoma.
Jing-Jing Li, Jiu-Hong Wang, Ya Dingv, Dan-Dan Li, Xi-Zhi Wen, Jing-Jing Zhao, Hang Jiang, Xing Liu, Fu-Xue Huang, Xiao-Shi Zhang. J Cancer Res Clin Oncol 2022
Jing-Jing Li, Jiu-Hong Wang, Ya Dingv, Dan-Dan Li, Xi-Zhi Wen, Jing-Jing Zhao, Hang Jiang, Xing Liu, Fu-Xue Huang, Xiao-Shi Zhang. J Cancer Res Clin Oncol 2022
Immunomodulatory Properties of Immune Checkpoint Inhibitors-More than Boosting T-Cell Responses?
Michael Kuske, Maximilian Haist, Thomas Jung, Stephan Grabbe, Matthias Bros. Cancers (Basel) 2022
Michael Kuske, Maximilian Haist, Thomas Jung, Stephan Grabbe, Matthias Bros. Cancers (Basel) 2022
Safety, activity, and pharmacokinetics of camrelizumab in advanced Asian melanoma patients: a phase I study.
Li Zhou, Xiaowen Wu, Zhihong Chi, Lu Si, Xinan Sheng, Yan Kong, Lili Mao, Bin Lian, Bixia Tang, Xieqiao Yan,[...]. BMC Cancer 2022
Li Zhou, Xiaowen Wu, Zhihong Chi, Lu Si, Xinan Sheng, Yan Kong, Lili Mao, Bin Lian, Bixia Tang, Xieqiao Yan,[...]. BMC Cancer 2022
Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathways.
Lukas Kraehenbuehl, Chien-Huan Weng, Shabnam Eghbali, Jedd D Wolchok, Taha Merghoub. Nat Rev Clin Oncol 2022
Lukas Kraehenbuehl, Chien-Huan Weng, Shabnam Eghbali, Jedd D Wolchok, Taha Merghoub. Nat Rev Clin Oncol 2022
18 F-FDG positron emission tomography-computed tomography has a low positive predictive value for detecting occult recurrence in asymptomatic patients with high-risk Stages IIB, IIC, and IIIA melanoma.
Zachary J Jaeger, Gregory A Williams, Ling Chen, Joyce C Mhlanga, Lynn A Cornelius, Ryan C Fields. J Surg Oncol 2022
Zachary J Jaeger, Gregory A Williams, Ling Chen, Joyce C Mhlanga, Lynn A Cornelius, Ryan C Fields. J Surg Oncol 2022
Immune checkpoint inhibitors for the treatment of melanoma.
Francesco Sabbatino, Luigi Liguori, Stefano Pepe, Soldano Ferrone. Expert Opin Biol Ther 2022
Francesco Sabbatino, Luigi Liguori, Stefano Pepe, Soldano Ferrone. Expert Opin Biol Ther 2022
Mesenchymal-epithelial transition factor (MET) immunoreactivity in positive sentinel nodes from patients with melanoma.
Evalyn E A P Mulder, Daniëlle Verver, Thom van der Klok, Calvin J de Wijs, Thierry P P van den Bosch, Maria J De Herdt, Berdine van der Steen, Cornelis Verhoef, Astrid A M van der Veldt, Dirk J Grünhagen,[...]. Ann Diagn Pathol 2022
Evalyn E A P Mulder, Daniëlle Verver, Thom van der Klok, Calvin J de Wijs, Thierry P P van den Bosch, Maria J De Herdt, Berdine van der Steen, Cornelis Verhoef, Astrid A M van der Veldt, Dirk J Grünhagen,[...]. Ann Diagn Pathol 2022
The cure from within? a review of the microbiome and diet in melanoma.
Priyanka Kumar, Danielle Brazel, Julia DeRogatis, Jennifer B Goldstein Valerin, Katrine Whiteson, Warren A Chow, Roberto Tinoco, Justin T Moyers. Cancer Metastasis Rev 2022
Priyanka Kumar, Danielle Brazel, Julia DeRogatis, Jennifer B Goldstein Valerin, Katrine Whiteson, Warren A Chow, Roberto Tinoco, Justin T Moyers. Cancer Metastasis Rev 2022
Resistance Mechanisms to Anti-PD Cancer Immunotherapy.
Matthew D Vesely, Tianxiang Zhang, Lieping Chen. Annu Rev Immunol 2022
Matthew D Vesely, Tianxiang Zhang, Lieping Chen. Annu Rev Immunol 2022
NeoSplice: a bioinformatics method for prediction of splice variant neoantigens.
Shengjie Chai, Christof C Smith, Tavleen K Kochar, Sally A Hunsucker, Wolfgang Beck, Kelly S Olsen, Steven Vensko, Gary L Glish, Paul M Armistead, Jan F Prins,[...]. Bioinform Adv 2022
Shengjie Chai, Christof C Smith, Tavleen K Kochar, Sally A Hunsucker, Wolfgang Beck, Kelly S Olsen, Steven Vensko, Gary L Glish, Paul M Armistead, Jan F Prins,[...]. Bioinform Adv 2022
Adaptive immune resistance at the tumour site: mechanisms and therapeutic opportunities.
Tae Kon Kim, Esten N Vandsemb, Roy S Herbst, Lieping Chen. Nat Rev Drug Discov 2022
Tae Kon Kim, Esten N Vandsemb, Roy S Herbst, Lieping Chen. Nat Rev Drug Discov 2022
Metabolic Implications of Immune Checkpoint Proteins in Cancer.
Elizabeth R Stirling, Steven M Bronson, Jessica D Mackert, Katherine L Cook, Pierre L Triozzi, David R Soto-Pantoja. Cells 2022
Elizabeth R Stirling, Steven M Bronson, Jessica D Mackert, Katherine L Cook, Pierre L Triozzi, David R Soto-Pantoja. Cells 2022
Biomarkers of treatment benefit with atezolizumab plus vemurafenib plus cobimetinib in BRAFV600 mutation-positive melanoma.
C Robert, K D Lewis, R Gutzmer, D Stroyakovskiy, H Gogas, S Protsenko, R P Pereira, T Eigentler, P Rutkowski, L Demidov,[...]. Ann Oncol 2022
C Robert, K D Lewis, R Gutzmer, D Stroyakovskiy, H Gogas, S Protsenko, R P Pereira, T Eigentler, P Rutkowski, L Demidov,[...]. Ann Oncol 2022